Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adolescent MenC booster vaccine study with concurrent acellular pertussis-containing booster
2012-005273-31Phase 3Completed
- Sponsor
- UK Health Security Agency
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Meningococcal group C polysaccharide conjugate vaccine, Hib-MenC-TT, Adacel Polio, acellular pertussis vaccine in meningococcal disease, pertussis, sponsored by UK Health Security Agency. Started May 2013; status: completed.
02
Drugs
Meningococcal group C polysaccharide conjugate vaccineHib-MenC-TTAdacel Polioacellular pertussis vaccine
03
Conditions
meningococcal diseasepertussis
Beyond the preview
Go deeper on 2012-005273-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005273-31.